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Introduction
The world has a massive shortage of 
health-care workers, currently estimated 
at over 4 million.1 Sub-Saharan Africa, 
the worst-affected region, has 25% of the 
world’s disease burden, yet 1.3% of the 
world’s health-care workers.2 With an 
estimated 600 000 health-care workers 
to serve a population of 682 million,3 
sub-Saharan Africa has one tenth of the 
doctors and nurses for its population 
that Europe does.1 An assessment of 
health-care worker availability against 
health system needs reveals stark gaps, 
with an estimated 720 000 physicians 
and 670 000 nurses needed in Africa 
to bridge the void.4 There are various 
contributory causes to the health-care 
worker crisis in Africa, but low training 
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capacity, poor working conditions, at-
trition and migration out of the health 
sector or out of the country are the most 
important factors.4
Sub-Saharan Africa is the epicentre 
of the HIV/AIDS epidemic, with 26 
million people (65% of the global to-
tal) infected with the virus.5 In severely 
affected countries, death is the major 
contributor to health-care worker short-
ages.6 Malawi, a small country in south-
ern Africa, faces a severe HIV/AIDS 
epidemic. By 1997, it was estimated 
that over 10% of health-care workers 
had died from AIDS.7 A formal study 
in 1999 in all district and main mission 
hospitals in the country found a 2% 
annual death rate in key health-care 
workers, with AIDS and tuberculosis 
being the most common causes.8
In the last few years, many African 
countries have been scaling up antiretro-
viral therapy (ART) for HIV-infected pa-
tients, and by December 2005, 840 000 
patients in Africa had started treatment.9 
Scaling-up of ART affects the health-care 
workforce in two ways. First, health-care 
workers are needed to run ART clinics, 
and as the case burden grows, this may 
be to the detriment of other health ser-
vices. Second, if HIV-infected health-
care workers access ART before they 
have severe immune suppression, this 
should keep the workforce alive and 
serving in public-sector institutions. To 
date, we have seen no national published 
data on: a) the proportion of health-
care workers used to deliver ART, and 
b) the uptake of ART by health-care 
workers and their outcomes while on 
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cohort on 30 June 2006, transferred out 
to another facility, stopped treatment, 
lost to follow-up for more than three 
months, death). Data were entered and 
cleaned in Microsoft Access and anal-
ysed using STATA version 9.2. Persons 
were considered to come under observa-
tion on the date of starting ART if they 
started during the free period or at the 
commencement of the national moni-
toring system in June 2004 if they had 
previously received ART. In this case, ac-
cumulated time on ART was considered 
in the survival analysis. Due to incom-
plete active ascertainment of deaths in 
the national monitoring and evaluation 
system, deaths, losses to follow-up and 
patients stopping ART were combined 
as the failure event. Observations were 
censored if the patient was alive and on 
ART by 30 June 2006 or if they were 
transferred to another facility before this 
time. The probability of survival on ART 
was estimated using the Kaplan–Meier 
method. Hazard ratios for survival were 
calculated after adjusting for background 
characteristics and Poisson regression 
was used for multivariate analyses. The 
impact of ART on health-care worker 
survival was analysed by comparing 
their observed survival to their pro-
jected survival based on mortality rates 
in Malawian patients from a natural 
history cohort assessed in the era before 
free ART.13
General measures are provided in 
all ART facilities to ensure confidential-
ity, consent for HIV testing, and coun-
selling and support for those who receive 
a positive HIV test result. Specific data 
collected for this study did not include 
personal identifiers. The Malawi National 
Health Science Research Committee 
provides general oversight and approval 
for the collection and use of routine 
programmatic data for monitoring and 
evaluation. The United States of America 
(US) Centres for Disease Control and 
Prevention considered this study pro-
gramme evaluation, which does not 
constitute human-subjects research.
Results
By 30 June 2006, 57 366 patients 
(53 853 adults and 3513 children aged 
14 years or less) had accessed ART in 
the 95 public-sector facilities in Malawi. 
At ART initiation, 5552 (9.7%) were in 
WHO clinical stage 1 or 2 with a low 
CD4 count, 38 122 (66.5%) were in 
stage 3 and 13 692 (23.9%) in stage 4. 
treatment. We therefore carried out a 
national operational study to investigate 
these issues.
Methods
Background
The process of ART scale-up in Malawi 
in the public sector has already been 
described,10 and only the main elements 
will be presented. By June 2004, only 
a few sites were delivering ART, and 
in the central hospitals patients had 
to pay for treatment. From June 2004 
onwards, delivery of ART free of charge 
was rolled out to all public-sector 
facilities. A standardized approach is 
used: the use of one generic, fixed-dose 
combination first-line treatment with 
stavudine, lamivudine and nevirapine; 
a system of registration, monitoring and 
reporting of cases and outcomes; and 
quarterly supervision and evaluation of 
all ART sites.11 HIV-positive patients 
are eligible for ART if they are in WHO 
clinical stage 3 or 4, or if their CD4-
lymphocyte count is 250/mm³ or less.12 
ART is only provided at Ministry of 
Health-accredited facilities according 
to national guidelines. Patients have 
appointments for clinical checkups and 
ARV dispensing at monthly intervals 
for the first six months, and thereafter 
follow-up visits are scheduled every two 
months for stable patients. If patients 
develop toxic side effects, there is a 
referral system for alternative first-line 
therapy. The process of ART scale-up in 
the private sector has followed a similar 
approach. The private sector provides 
ART at subsidized cost (US$ 3.50 per 
course of treatment per month), and also 
uses Malawi’s national ART monitoring 
and evaluation system.
When patients visit ART clinics 
each month, vital data are recorded using 
standardized monitoring tools. There is 
one ART patient treatment master card 
for each patient and one ART register 
per facility.10 Patients are registered 
with their demographic details, occupa-
tion, initial clinical staging and ART 
initiation date on master cards and in 
the register. Standardized outcomes and 
follow-up details are recorded monthly 
on master cards, then the latest follow-up 
status for each patient is updated to the 
ART register. Due to constrained re-
sources, active follow-up of patients who 
fail to return to the clinic is not always 
possible. Despite this, more than half of 
the facilities regularly attempt to trace 
defaulters through community visits.
The health ministry’s HIV unit and 
its partners conduct quarterly supervi-
sory and monitoring visits to all ART 
sites in the country. The monitoring 
teams check the registers’ accuracy and 
completeness and compare treatment 
master card details with entries to the 
register. Every three months, a quarterly 
cohort analysis is performed on the most 
recent three-month cohort of patients 
started on ART and the cumulative co-
hort of patients ever started on therapy, 
with outcomes censored at the end of 
the respective quarter.11
Data collection and analysis
All 95 ART facilities in the public sector 
and all 28 ART facilities in the private 
sector were visited between July and 
September 2006. Data for the April to 
June 2006 quarter and for all patients 
ever started on ART were collected, 
with treatment outcomes censored on 
30 June 2006. Data were then entered 
into a Microsoft Excel spreadsheet for 
collation.
At each ART facility in the public 
sector, a standard form was used to col-
lect information on the work time of 
clinicians, nurses and clerks allocated 
to the ART clinic. The total current 
contingent of health staff was obtained 
from the facility’s administration. For 
the analysis, staff cadres were catego-
rized into clinicians (doctors, clinical 
officers and medical assistants), trained 
nurses and ward clerks. In each facility 
clinic, the number of days or half-days 
allocated per week to ART service de-
livery, and the number of clinicians, 
nurses and clerks at the clinic on those 
days were documented. From this in-
formation, the staffing impact of ART 
clinics on the general health services was 
estimated at the national level as the 
proportion of clinician, nurse and clerk 
days used to run ART services.
From ART registers in the public 
and private sector, data were collected 
from the occupation column on the 
number of health-care workers who 
had ever accessed ART from the start of 
the service up to 30 June 2006. When 
a health-care worker was identified, the 
following information was obtained: 
health-care worker cadre (information 
provided by ART clinic staff), age, sex, 
date and reason for starting ART, in-
cluding whether tuberculosis (TB) was 
a cause. The date and reason for termi-
nation of observation were recorded 
(retained alive on ART at closure of the 
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By 30 June 2006, 41 549 (72.4%) 
patients were alive and on ART at the 
facility where they had first registered. 
A cohort analysis showed that 70.2% 
of 7647 patients were alive and on ART 
at 6 months, and 62.5% of 5316 were 
alive and on ART at 12 months. By 30 
June 2006, there were 2215 patients 
(2125 adults and 90 children) in the 
private sector who had ever started on 
ART from 28 facilities. Of these, 1931 
(87.2%) were alive and on ART at the 
facility where they had first registered.
A total of 939 clinicians (187 doc-
tors, 550 clinical officers and 202 medi-
cal assistants), 2376 nurses and 251 
ward clerks were working at the 95 
public-sector facilities that provided 
ART. Assuming an annual average of 
230 days worked (4.4 days/week) by 
each staff member, the total staff work-
days per week available for health ser-
vice delivery for clinicians, nurses and 
clerks are shown in Table 1. ART services 
were provided on a total of 224 clinic-
days per week, equivalent to an average 
of 2.4 days per facility. The number of 
clinician-, nurse- and clerk-staff work-
days required for ART services are also 
shown in Table 1.
Health-care workers and ART
Occupation was known for 56 630 
(95.0%) of the total national ART-
patient cohort (59 581). Of these, 1024 
(1.8%) were health-care workers; two 
had unknown outcome data and were 
excluded from further analysis. There 
were 363 men and 659 women, whose 
mean age was 39.7 years (range 19–65 
years). The public sector had registered 
973 and the private sector 49 (4.8%) 
health-care workers. There were 73 
clinicians (7 doctors, 44 clinical officers 
and 22 medical assistants), 225 nurses, 
232 ward support staff, 387 ancillary 
staff (e.g. hospital technicians, health 
Table 1. National health-care worker allocation to ART clinic services in the public sector
Clinician  
days/week
Nurse  
days/week
Clerk  
days/week
Total health-care  
worker days/week
A.  Number of staff workdays per week available 
for all health service delivery at the public 
hospitals and health centres providing ART 
servicesa
4 131 10 454 1 104 15 689
B.  Number (%) of staff workdays per week 
required for ART services
300 (7.2%) 355 (3.4%) 261 (23.6%) 916 (5.8%)
ART, antiretroviral therapy.
a  Assumption: 230 days worked by each staff member per year.
surveillance assistants) and 105 of un-
known cadre. Clinical stage at ART 
initiation was documented in 916 cases: 
148 (16.2%) started in WHO clinical 
stage 1 or 2 with a low CD4 count, 529 
(57.8%) in stage 3 and 239 (26.1%) 
in stage 4. Tuberculosis was a common 
stage-defining condition in 192 (18.8%) 
health-care workers, and was signifi-
cantly more common in ward support 
staff (23.3%) compared with all other 
cadres (13.3%; P < 0.001).
Of health-care workers started on 
ART, more nurses (24.0%) and clini-
cians (16.4%) had accessed therapy at 
the time when this treatment had to 
be paid for compared with other cad-
res (7.5%), and had therefore a longer 
average exposure to ART. The median 
observation time for patients on free 
ART was 8.4 months.
By 30 June 2006, 793 (77.6%) 
health-care workers were alive and on 
ART at their registration facility, 119 
(11.6%) had died, 5 (0.5%) had stopped 
treatment, 65 (6.4%) had transferred 
to another facility and 40 (3.9%) were 
lost to follow-up. The probability of be-
ing alive and on ART at 6, 12 and 18 
months was 85.1%, 81.3% and 78.2% 
respectively (see Fig. 1). Univariate 
analysis showed that the probability of 
staying alive and on ART was higher 
in women (hazard ratio, HR 1.61), in 
nurses (HR 1.89) and in patients start-
ing ART in WHO stage 1 or 2 with a 
low CD4 count (HR 2.44); see Table 2. 
After adjusting for gender, health-care 
worker cadre and WHO stage, only 
patients with stage 1 or 2 with a low 
CD4 count had a significantly higher 
probability of staying alive and on ART 
(HR 3.05).
Table 3 shows the impact of ART 
on survival of the health-care worker 
cohort by using data from the natural 
history cohort, as described above.13 
Health-care workers in stages 3 and 4 
experienced a 70% reduction in mor-
tality at 12 months. There was no 
Fig. 1. Survival probability in health-care workers starting ARTa
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ARV, antiretroviral therapy.
a  N = 1 022; 875 life-years of observation.
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Table 2. Factors in health-care workers associated with an increased probability of staying alive and on ART
n % of N Crude 1/HR  
(95% CI)
Adjusted 1/HR  
(95% CI)a
Sex
Men 363 35.5% 1 – 1 –
Women 659 64.5% 1.61 (1.18–2.17) 1.37 (0.92–2.03)
Age starting ART
19–34 years 263 25.7% 1 – 1 –
35–44 years 465 45.5% 0.90 (0.61–1.30) 0.95 (0.63–1.42)
45–65 years 283 27.7% 1.16 (0.76–1.79) 1.07 (0.67–1.71)
Unknown 11 1.1% – – – –
WHO clinical stage at start of ART
1 or 2, CD4 < 250 176 17.2% 2.44 (1.37–4.27) 3.05 (1.53–6.10)
3 580 56.8% 1 – 1 –
4 265 25.9% 0.73 (0.52–1.01) 0.72 (0.51–1.02)
Unknown 1 0.1% – – – –
Heath-care worker cadre
MO, CO, MA 73 7.1% 0.83 (0.48–1.43) 0.87 (0.49–1.54)
Nurses 225 22.0% 1.89 (1.23–2.94) 1.57 (0.96–2.57)
Ward support staff 232 22.7% 1.23 (0.81–1.85) 1.14 (0.74–1.74)
Ancillary staff 387 37.9% 1 – 1 –
Unknown 105 10.3% – – – –
Total 1 022 – – – – –
ART, antiretroviral therapy; CI, confidence interval; CO, clinical officer; HR, hazard ratio; MA, medical assistant; MO, medical officer.
a  HR adjusted for gender, WHO clinical stage and health-care worker cadre.
significant 12-month survival benefit 
in health-care workers in stage 1 or 2, 
although these patients may have been 
more immunosuppressed than those 
in the natural history cohort by virtue 
of all having a CD4 count of less than 
250/mm³. Based on the distribution of 
clinical stages in the health-care worker 
cohort, 257 health-care workers were 
projected to survive at 12 months after 
treatment initiation who would other-
wise have died without ART.
Discussion
This is the first report from sub-Saharan 
Africa examining the important interac-
tion between ART scale-up and health-
care workers at a national level. In the 
public-sector ART facilities, 7% of cli-
nician time and 3% of nursing time was 
allocated for delivering ART services. 
This allocation had allowed over 57 000 
patients to access ART, with over 40 000 
being followed up on a monthly basis. 
The small proportion of health-care 
workers’ time spent on delivering ART 
to large numbers of patients reflects the 
simple, standardized approach to ART 
care that Malawi has developed.10
The official 2006 statistics of health-
care workers in government and mission 
sectors of Malawi14 enumerated 1278 
clinicians (doctors, clinical officers and 
medical assistants) and 2720 nurses. 73 
clinicians and 225 nurses were on ART. 
If they were all from the government and 
mission sectors, this would constitute 
5.7% of clinicians and 8.3% of nursing 
the workforces respectively. An unknown 
proportion of clinicians and nurses in our 
health-care workers cohort were likely 
to have been from private or nongovern-
mental facilities, and the preservation of 
their work capacity through ART would 
therefore not directly benefit the public 
health sector. However, Malawi’s private 
and nongovernmental health sector is 
small and the estimation of the positive 
impact of ART on human resources in 
the public sector is still likely to be valid. 
The uptake of ART among health-care 
workers contrasts with that of the adult 
general population of Malawi (estimated 
at 5.5-6 million),15 where about 1% 
of people so far have started on ART. 
The reasons are speculative, but would 
include health-care workers’ better and 
easier access to hospital laboratories and 
ART clinics, and a better understanding 
of the life-saving effects of medication.
The majority of health-care work-
ers had accessed free ART in the public 
sector, while 4% opted for service at 
subsidized cost in the private sector, pos-
sibly for reasons of confidentiality. Treat-
ment outcomes were good. Although 
direct comparisons with the general 
patient cohort analysis are not valid due 
to differences in data ascertainment and 
analysis, health-care workers had a con-
siderably better survival probability at 6 
and 12 months. One of the likely reasons 
is that more health-care workers started 
ART in earlier disease stages, as those in 
stages 1 and 2 had improved outcomes 
relative to patients who started in stages 
3 and 4. Strategies to further increase 
the access of individuals, including 
health-care workers, to CD4 testing 
and ART are important, as this may 
increase longer-term survival and reduce 
morbidity to decrease the HIV-related 
burden on the health-care system.
Access to ART had saved the lives 
of at least 250 out of 1022 health-care 
workers after 12 months of treatment. 
This is a conservative estimate, because 
deaths as well as treatment stops and 
clinic defaults were interpreted as “fail-
ure to survive on ART” in the survival 
analysis. It is known from the national 
cohort reports that 85–95% of patients 
alive and on ART are ambulatory and 
able to work.11 Assuming similar rates 
for the health-care-worker cohort, the 
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Table 3. Mortality rates and cumulative 12-month survival probabilities for health-care workers on ART and projected survival 
based on mortality rates from a natural history cohort in Malawi from the era before free ART13
Health-care worker cohort on ART Malawi natural history cohort
WHO
clinical
stage
n MR/100 pyrsa  
(95% CI)
12-month survival MR/100 pyrsa  
(95% CI)
MRR d 12-month survival
Survival
probabilityb
No.
alivec
Survival
probabilityb
No.
alivec
1 or 2 176 8 (5–13) 92% 162 5 (2–12) 1.6 95% 167
3 580 19 (15–23) 83% 480 62 (42–86) 0.3 54% 312
4 265 26 (20–34) 77% 204 88 (35–180) 0.3 41% 110
Total 1 021 – – – 846 – – – – 589
ART, antiretroviral therapy; CI, confidence interval; MR, mortality rate; MRR, mortality rate ratio; pyrs, person-years.
a  Failure events (deaths, treatment stops and clinic defaults) per 100 person-years of observation. Follow-up studies in Malawi have shown that the majority of 
ART clinic defaulters are unrecognized deaths (unpublished data). In the natural history cohort, failure events are actual deaths only. 
b  Cumulative probability of survival at 12 months after ART initiation. For the natural history cohort, the estimate is based on e(-MR*1) of the 1-year mortality rates 
quoted in the study, assuming an approximately constant mortality rate over the first 12 months. To improve comparability, the same method was used for the 
health-care worker cohort (the actual cumulative survival probabilities based on the Kaplan–Meier method were 89%, 82% and 77%, respectively).
c  Projection of the number of health-care workers alive by 12 months after ART initiation, estimated as the number of individuals in each clinical stage category 
multiplied by the respective survival probability.
d  MRR = MR of health-care worker on ART / MR of natural history cohort.
250 who survived due to ART would 
account for a gain of 1000 health-care 
worker days per week at the national 
level. This balances favourably against 
the approximately 1000 health-care 
worker days per week that are required 
for ART service provision at the na-
tional level.
This operational study used data 
from the routine national monitoring 
system and therefore has some limita-
tions. The actual work hours of clini-
cians, nurses and clerks on ART clinic 
days were unknown, and we have not 
accounted for the time managing ART 
patients who require hospital admis-
sion. For the calculation of the total 
work time denominator, we have as-
sumed that health-care workers provide 
230 full days annually, which is likely 
to be an overestimate as staff absentee-
ism may be high in government health 
services. Occupation was unknown for 
some patients, and clinic staff members 
indicated that some health-care work-
ers had registered under different names 
and occupations to avoid identification. 
Thus, we have probably underestimated 
the number of health-care workers who 
were treated with ART. The transfer of 
patients between sites leads to a duplica-
tion of observation time, and this will 
have led to an overestimation of survival 
probabilities. However, since only about 
7% of ART patients in the national 
cohort are transfers, the effect is likely 
to be small.
The strengths of the study are that it 
is a national, comprehensive survey, and 
we are not aware of facilities providing 
ART in Malawi that are not included in 
this study. The national monitoring sys-
tem for ART is standardized and used by 
all public and private facilities. Routine 
validation of data is carried out during 
quarterly supervision of all sites through 
cross-checking of ART treatment mas-
ter cards and ART registers, resulting in 
relatively high data quality.
In the future, the further gains of 
placing health-care workers on ART 
may not keep pace with increased staff-
ing needs for ART service delivery as 
more Malawians access HIV treatment. 
The programme will then pose an 
increasing demand on the health-care 
system, and this may affect the quality 
of general health service delivery.16 With 
Malawi having one of the world’s worst 
ratios of doctors and nurses per capita,17 
ART delivery will have to rely on less 
skilled personnel if general health ser-
vices are to be maintained.  ■
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Résumé
Enquête nationale consacrée aux effets du passage rapide à l’échelle supérieure du programme de 
traitement antirétroviral sur les agents de santé au Malawi : impact en termes de ressources humaines 
et de survie
Objectif Evaluer l’impact en termes de ressources humaines du 
développement rapide du programme de traitement antirétroviral 
(ART) au Malawi et le confronter au bénéfice lié à la survie des agents 
de santé ayant eu accès pour eux-mêmes au traitement ART.
Méthodes Nous avons mené une enquête transversale à 
l’échelle du Malawi sur la répartition des ressources humaines 
dans tous les établissements médicaux publics délivrant le 
traitement ART depuis mi-2006. Nous avons également effectué 
une analyse du taux de survie des agents de santé ayant, au 
30 juin 2006, eu accès au traitement antirétroviral dans des 
établissements médicaux publics ou privés à partir des données 
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Objetivo Evaluar el impacto que ha tenido en los recursos 
humanos el programa de terapia antirretroviral (TAR) rápidamente 
extendido en Malawi, contrastando ese dato con los beneficios 
logrados en lo relativo a la supervivencia de los trabajadores 
sanitarios que han accedido a la TAR.
Métodos Realizamos una encuesta transversal nacional 
sobre la distribución de los recursos humanos en todos los 
establecimientos de salud del sector público que proporcionaban 
TAR a mediados de 2006. Llevamos a cabo también un análisis 
de supervivencia de los trabajadores sanitarios que habían tenido 
acceso a la TAR en centros públicos y privados hasta el 30 de 
junio de 2006, utilizando para ello datos del sistema nacional de 
vigilancia  y evaluación de la TAR.
Resultados A 30 de junio de 2006, 59 581 pacientes habían 
accedido a la TAR en 95 centros públicos y 28 privados. Los 
centros públicos ofrecían servicios de TAR 2,4 días a la semana 
por término medio y absorbían un 7% del personal médico, el 
Resumen
Encuesta nacional sobre el impacto de la expansión rápida de la terapia antirretroviral en los trabajadores 
sanitarios en Malawi: efectos en los recursos humanos y la supervivencia
3% del personal de enfermería, y un 24% de los auxiliares 
administrativos de los establecimientos. Identificamos a 1024 
trabajadores sanitarios de la cohorte nacional de pacientes 
tratados con TAR (2% de todos los pacientes sometidos a TAR). 
Las probabilidades de supervivencia entre quienes recibían TAR a 
los 6 meses, 12 meses y 18 meses eran de un 85%, 81% y 78%, 
respectivamente. A los 12 meses de dar comienzo a la TAR, se 
estima que se había salvado la vida a unos 250 trabajadores 
sanitarios. Su tiempo de trabajo combinado, más de 1000 días-
persona por semana, equivalía a los recursos humanos requeridos 
para proporcionar la TAR a nivel nacional.
Conclusión Un gran número de pacientes sometidos a TAR en 
Malawi son tratados por una pequeña proporción de la fuerza 
laboral sanitaria. Muchos trabajadores sanitarios han accedido a 
la TAR con buenos resultados terapéuticos. Actualmente el personal 
requerido para administrar la TAR es similar al mantenido con vida 
gracias al tratamiento, pero esto podría cambiar en el futuro.
fournies par le système national de surveillance et d’évaluation 
des ART.
Résultats En juin 2006, 59 581 patients avaient eu accès au 
traitement ART dans le cadre d’un établissement médical public 
(95 établissements) ou privé (28 établissements). En moyenne, 
les établissements publics délivraient ce traitement sur 2,4 jours 
par semaine et utilisaient pour ce faire 7 % de leur personnel 
clinique, 3 % de leur personnel infirmier et 24 % de leur 
personnel administratif. Nous avons identifié 1024 agents de 
santé parmi la cohorte nationale de personnes ayant bénéficié 
d’un traitement ART (soit 2 % de l’effectif total de cette cohorte). 
Les probabilités de survie sous ART à 6 mois, 12 mois et 18 mois 
étaient respectivement de 85, 81 et 78 %. On estime à 250 le 
nombre d’agents de santé qui ont été maintenus en vie 12 mois 
après le début de leur traitement. Au total, le temps de travail 
préservé correspondant représente plus de 1000 personnes-jours 
par semaine, soit l’équivalent des ressources nécessaires pour 
délivrer le traitement ART à l’échelle du pays.
Conclusion Un grand nombre de patients sous ART ont été pris 
en charge au Malawi par une faible proportion du personnel 
médical. Nombre d’agents de santé ont eu accès au traitement 
antirétroviral avec de bons résultats thérapeutiques. Actuellement, 
les besoins en personnel pour la délivrance du traitement ART sont 
équivalents aux ressources humaines préservées par le maintien 
en vie, grâce au traitement, des agents de santé malades, cette 
situation pouvant néanmoins évoluer dans l’avenir.
صخلم
ةيعوجرلا تاسويرفلا تاداضبم ةجلاعلما جمانبرـب عيسرلا ءاقترلاا يرثأت لوح ينطو حسم
ةايحلا ديق لىع ءاقبلاو ةيشربلا دراولما لىع هتايرثأت :يولاام في ةيحصلا ةياعرلا يفظوم لىع
 تاسويرفلا تاداضبم ةجلاعلما جمانبرـب عيسرلا ءاقترلاا يرثأت ميـيقت :فدهلا
 ةيحصلا ةياعرلا يفظوم ايقب نم ةلصحتلما ةدئافلاب كلذ ةنزاومو ةيرقهقلا
.يرقاقعلا هذهب ةجلاعلما مهل تحيتأ نيذلا
 دراولما  عيزوت  لوح  ًاضرعتسم  ًاينطو  ًاحسم  نوثحابلا  ىرجأ  :ةقيرطلا
 رفوت  يتلا  ماعلا  عاطقلل  ةعباتلا  ةيحصلا  ةياعرلا  قفارم  عيمج  في  ةيشربلا
 ىرجأ ماك .2006 فصتنم في كلذو ،ةيعوجرلا تاسويرفلا تاداضبم ةجلاعلما
 ةجلاعلما  مهل  تحيتأ  نيذلا  ةيحصلا  ةياعرلا  يفظوم ايقبل  ًلايلحت نوثحابلا
 ،2006  وينوي/ناريزح  30  ىتح  ةصاخلاو  ةماعلا  قفارلما  في  يرقاقعلا  هذهب
 ةجلاعلما  ميـيقتو  دصرل  ينطولا  ماظنلا  نم  ةدمتسم  تايطعم  ينمدختسم
.ةيعوجرلا تاسويرفلا تاداضبم
 ةجلاعلما ،2006 وينوي/ناريزح 30 ىتح ،ًاضيرم 59 581ىقلت :تادوجولما
 ًايحص ًاقفرم 28و ،ًاماع ًايحص ًاقفرم 95 في ،ةيعوجرلا تاسويرفلا تاداضبم
 في ًاموي  2.4  لدعبم يرقاقعلا  هذهب ةجلاعلما  ةماعلا  قفارلما  تم َّدقو ،ًاصاخ
 ،ينـيريسرلا  ءابطلأا  نم ةلماعلا  ىوقلا  نم %7  دوجو بَّلطت  مام عوبسلأا
 ةبتك نم ةلماعلا ىوقلا نم %24و ،ضيرمتلا نم ةلماعلا ىوقلا نم %3و
 ةياعرلا يفظوم نم 1024 نأ نوثحابلا دجوو .قفارلما هذهب ةرفوتلما ةحنجلأا
 ةـعومجم  نمض  ةيعوجرلا  تاسويرفلا  تاداضبم  ةجلاعلما  نوقلتي  ةيحصلا
 عومجم نم %2( يرقاقعلا هذـهب ةـجلاعلما نوقلتي نيذلا ينـينطولا ضىرلما
 ةبسن  تغلبو  .)ةيعوجرلا  تاسويرفلا  تاداضبم  نوجلاعي  نيذلا  ضىرلما
 نم رهشأ 6 دعب ةيعوجرلا تاسويرفلا تاداضبم ةجلاعلما عم ايقبلا لماتحا
 نكمأو  .%78  ًارهش  18  دعبو  ،%81ً  ارهش  12  دعبو  ،%85  ةجلاعلما  ءدب
 ةجلاعلما ءدب نم ارهش 12 دعب ةيحص ةياعر فظوم 250 وحن ةايح ذاقنإ
 موي  1000  نم ثركأ  غلب  يذلا  عّمجلما  مهلمع تقو ناكو .ً  يرقاقعلا  هذهب
 تاداضبم ةجلاعلما يرفوتل ةبولطلما ةيشربلا دراوملل ًايواسم عوبسلأا في لمع
  .ينطولا ىوتسلما لىع ةيعوجرلا تاسويرفلا
 يربدتلا  لىوتي  ةيحصلا  ةياعرلا  يفظوم  نم  يرغص  مسق  كانه  :جاتنتسلاا
 تاسويرفلا تاداضبم ةجلاعلما نوقلتي نيذلا ضىرلما نم مخض ددعل يجلاعلا
 ةياعرلا يفظوم نم ديدعلل يرقاقعلا هذهب ةجلاعلما تحيتأ دقو .ةيعوجرلا
 يفظوم ةايح نإف نلآاو .ةديج ةيجلاع لئاصح نع ترفسأ يتلاو ةيحصلا
 ةبولطلما ةلماعلا لداعت ةجلاعلما للاخ نم اهذاقنإ نكمأ يتلا ةيحصلا ةياعرلا
 رملأا اذه يرغت ةيناكمإ مغر ،ةيعوجرلا تاسويرفلا تاداضبم ةجلاعلما يرفوتل
.ًلابقتسم
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